Stoke Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of STOK for the last quarter is 4.83 M USD, and it's 14.59% higher compared to the previous quarter. The net income of Q2 24 is -25.70 M USD.